Based on this, there is very little evidence to speculate about the association between FLT3 ITD mutations and occurrence of GS even why we were not able to demonstrate the presence of FLT3-ITD mutation in the mastoid sarcoma tissue. The gene discussed is FLT3; the disease is sarcoma.